BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17315920)

  • 1. Catalytic activity tuning of a biomimetic HO-FeV=O oxidant for methane hydroxylation by substituents on aromatic rings: theoretical study.
    Ma Y; Balbuena PB
    J Phys Chem B; 2007 Mar; 111(10):2711-8. PubMed ID: 17315920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A density functional study on a biomimetic non-heme iron catalyst: insights into alkane hydroxylation by a formally HO-FeV=O oxidant.
    Bassan A; Blomberg MR; Siegbahn PE; Que L
    Chemistry; 2005 Jan; 11(2):692-705. PubMed ID: 15580652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the ruthenium analogue of compound I of cytochrome p450 an efficient oxidant? A theoretical investigation of the methane hydroxylation reaction.
    Sharma PK; De Visser SP; Ogliaro F; Shaik S
    J Am Chem Soc; 2003 Feb; 125(8):2291-300. PubMed ID: 12590559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in substrate hydroxylation reactions by heme and nonheme iron(IV)-oxo oxidants give correlations between intrinsic properties of the oxidant with barrier height.
    de Visser SP
    J Am Chem Soc; 2010 Jan; 132(3):1087-97. PubMed ID: 20041691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamental differences of substrate hydroxylation by high-valent iron(IV)-oxo models of cytochrome P450.
    Tahsini L; Bagherzadeh M; Nam W; de Visser SP
    Inorg Chem; 2009 Jul; 48(14):6661-9. PubMed ID: 19469505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the bound substrate in nitric oxide synthase protonated or neutral and what is the active oxidant that performs substrate hydroxylation?
    de Visser SP; Tan LS
    J Am Chem Soc; 2008 Oct; 130(39):12961-74. PubMed ID: 18774806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect and influence of cis-ligands on the electronic and oxidizing properties of nonheme oxoiron biomimetics. A density functional study.
    de Visser SP; Nam W
    J Phys Chem A; 2008 Dec; 112(50):12887-95. PubMed ID: 18616332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The axial ligand effect on aliphatic and aromatic hydroxylation by non-heme iron(IV)-oxo biomimetic complexes.
    de Visser SP; Latifi R; Tahsini L; Nam W
    Chem Asian J; 2011 Feb; 6(2):493-504. PubMed ID: 21254427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron catalyzed competitive olefin oxidation and ipso-hydroxylation of benzoic acids: further evidence for an Fe(V)═O oxidant.
    Das P; Que L
    Inorg Chem; 2010 Oct; 49(20):9479-85. PubMed ID: 20866083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ortho-Hydroxylation of aromatic acids by a non-heme Fe(V)=O species: how important is the ligand design?
    Ansari A; Rajaraman G
    Phys Chem Chem Phys; 2014 Jul; 16(28):14601-13. PubMed ID: 24812659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A theoretical study on the mechanism of camphor hydroxylation by compound I of cytochrome p450.
    Kamachi T; Yoshizawa K
    J Am Chem Soc; 2003 Apr; 125(15):4652-61. PubMed ID: 12683838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron-promoted ortho- and/or ipso-hydroxylation of benzoic acids with H(2)O(2).
    Makhlynets OV; Das P; Taktak S; Flook M; Mas-Ballesté R; Rybak-Akimova EV; Que L
    Chemistry; 2009 Dec; 15(47):13171-80. PubMed ID: 19876966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insights on the ortho-hydroxylation of aromatic compounds by non-heme iron complex: a computational case study on the comparative oxidative ability of ferric-hydroperoxo and high-valent Fe(IV)═O and Fe(V)═O intermediates.
    Ansari A; Kaushik A; Rajaraman G
    J Am Chem Soc; 2013 Mar; 135(11):4235-49. PubMed ID: 23373840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of an alternative to the H-atom abstraction mechanism in methane C-H bond activation by nonheme iron(IV)-oxo oxidants.
    Tang H; Guan J; Liu H; Huang X
    Dalton Trans; 2013 Jul; 42(28):10260-70. PubMed ID: 23732441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined experimental and theoretical study on aromatic hydroxylation by mononuclear nonheme iron(IV)-oxo complexes.
    de Visser SP; Oh K; Han AR; Nam W
    Inorg Chem; 2007 May; 46(11):4632-41. PubMed ID: 17444641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the mu-oxo-mu-peroxodiiron intermediate of a ribonucleotide reductase biomimetic a possible oxidant of epoxidation reactions?
    de Visser SP
    Chemistry; 2008; 14(15):4533-41. PubMed ID: 18386299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of compound II: electronic structure analysis of methane hydroxylation by oxoiron(IV) porphyrin complexes.
    Rosa A; Ricciardi G
    Inorg Chem; 2012 Sep; 51(18):9833-45. PubMed ID: 22946694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin of the correlation of the rate constant of substrate hydroxylation by nonheme iron(IV)-oxo complexes with the bond-dissociation energy of the C-H bond of the substrate.
    Latifi R; Bagherzadeh M; de Visser SP
    Chemistry; 2009 Jul; 15(27):6651-62. PubMed ID: 19472231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regioselectivity of aliphatic versus aromatic hydroxylation by a nonheme iron(II)-superoxo complex.
    Latifi R; Tahsini L; Nam W; de Visser SP
    Phys Chem Chem Phys; 2012 Feb; 14(7):2518-24. PubMed ID: 22252092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axial ligand effect on the rate constant of aromatic hydroxylation by iron(IV)-oxo complexes mimicking cytochrome P450 enzymes.
    Kumar D; Sastry GN; de Visser SP
    J Phys Chem B; 2012 Jan; 116(1):718-30. PubMed ID: 22132821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.